Therefore, elucidating the detailed molecular mechanism of the gephyrin-independent regulation of GABAAR lateral mobility might contribute not only to understanding the basis of learning and memory but also to discovering therapeutic targets for neuropathies such as epilepsy. This evidence concerns the gene GPHN and neuropathy.